Remove Doctors Remove Marketing Remove Pharma Companies Remove Regulation
article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.

Marketing 100
article thumbnail

The social media problem for healthcare

World of DTC Marketing

Earlier this year, I was asked by a client to write a position paper on using Facebook for the DTC marketing of an oncology product. A year ago, Facebook was making a hard charge to get the pharma business. TV will still be the first choice for many DTC marketers, but digital is increasing even though 50% of that money is wasted.

Branding 224
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Another reason change is needed at FDA? Fair balance

World of DTC Marketing

As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. To portray patients, mindless people who blindly believe DTC TV ads and rush to their doctor to ask for a product are inaccurate. Prescription drugs are not the same as items found in a grocery store.

Doctors 165
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Google is also giving health records another whirl.

Pharmacy 227
article thumbnail

Veeva Systems Summit, Madrid – pharmaphorum reflects

pharmaphorum

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e.

article thumbnail

High hopes as Inventiva takes NASH contender into phase 3

pharmaphorum

The regulator said it wanted more long-term safety and efficacy data from the REGENERATE study before making a final decision on the drug, which had been expected to be the first entrant into a likely multi-billion dollar market niche. billion annually if approved.

article thumbnail

Growth Of Pharma Franchise in India

Creogenic Pharma

Franchise Company. Growth of Pharma Franchise: With the rise in competition, it has truly become demanding for new businesses to enter the present pharmaceutical production marketplace. The operational and marketing skills could be developed with time, but the lack of tools can damage your business very poorly. Distributor ?